{
  "prompt_id": "stage_c_03",
  "stage": "C",
  "generated_at": "2025-10-18T18:31:33.097955Z",
  "metrics": {
    "tool_routing": {
      "score": 0.0,
      "details": {
        "expected": [
          "research_guidelines"
        ],
        "observed": [
          "legacy_arxiv_search",
          "web_search"
        ],
        "missing": [
          "research_guidelines"
        ],
        "extra": [
          "legacy_arxiv_search",
          "web_search"
        ]
      }
    },
    "citation_presence": {
      "score": 1.0
    },
    "citation_validity": {
      "score": 1.0,
      "details": {
        "total_count": 8,
        "scholarly_count": 8,
        "guideline_count": 0,
        "portal_count": 0,
        "other_count": 0,
        "malformed_count": 0,
        "domain_config_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367"
      },
      "citations": [
        {
          "id": "P1",
          "title": "Towards AI-Based Precision Oncology: A Machine Learning Framework for Personalized Counterfactual Treatment Suggestions based on Multi-Omics Data",
          "url": "http://arxiv.org/abs/2402.12190v2",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P2",
          "title": "Deep Learning in Computational Biology: Advancements, Challenges, and Future Outlook",
          "url": "http://arxiv.org/abs/2310.03086v1",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P3",
          "title": "Structure-based drug discovery with deep learning",
          "url": "http://arxiv.org/abs/2212.13295v1",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P4",
          "title": "Social and environmental impact of recent developments in machine learning on biology and chemistry research",
          "url": "http://arxiv.org/abs/2210.00356v1",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P5",
          "title": "Opportunities in deep learning methods development for computational biology",
          "url": "http://arxiv.org/abs/2406.08686v1",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P6",
          "title": "Computational model discovery with reinforcement learning",
          "url": "http://arxiv.org/abs/2001.00008v1",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P7",
          "title": "Building Flexible, Scalable, and Machine Learning-ready Multimodal Oncology Datasets",
          "url": "http://arxiv.org/abs/2310.01438v2",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        },
        {
          "id": "P8",
          "title": "Circuit design in biology and machine learning. I. Random networks and dimensional reduction",
          "url": "http://arxiv.org/abs/2408.09604v2",
          "domain": "arxiv.org",
          "kind": "scholarly",
          "malformed": false
        }
      ],
      "legacy_quality_score": 63.0,
      "legacy_validator": {
        "valid": false,
        "valid_count": 0,
        "total_count": 8,
        "issues": [
          "Citation 1: No authors specified",
          "Citation 1: Invalid or missing year",
          "Citation 1: No venue specified",
          "Citation 1: No DOI available",
          "Citation 1: No meaningful snippet",
          "Citation 2: No authors specified",
          "Citation 2: Invalid or missing year",
          "Citation 2: No venue specified",
          "Citation 2: No DOI available",
          "Citation 2: No meaningful snippet",
          "Citation 3: No authors specified",
          "Citation 3: Invalid or missing year",
          "Citation 3: No venue specified",
          "Citation 3: No DOI available",
          "Citation 3: No meaningful snippet",
          "Citation 4: No authors specified",
          "Citation 4: Invalid or missing year",
          "Citation 4: No venue specified",
          "Citation 4: No DOI available",
          "Citation 4: No meaningful snippet",
          "Citation 5: No authors specified",
          "Citation 5: Invalid or missing year",
          "Citation 5: No venue specified",
          "Citation 5: No DOI available",
          "Citation 5: No meaningful snippet",
          "Citation 6: No authors specified",
          "Citation 6: Invalid or missing year",
          "Citation 6: No venue specified",
          "Citation 6: No DOI available",
          "Citation 6: No meaningful snippet",
          "Citation 7: No authors specified",
          "Citation 7: Invalid or missing year",
          "Citation 7: No venue specified",
          "Citation 7: No DOI available",
          "Citation 7: No meaningful snippet",
          "Citation 8: No authors specified",
          "Citation 8: Invalid or missing year",
          "Citation 8: No venue specified",
          "Citation 8: No DOI available",
          "Citation 8: No meaningful snippet"
        ],
        "individual_results": [
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          },
          {
            "valid": false,
            "score": 63.0,
            "issues": [
              "No authors specified",
              "Invalid or missing year",
              "No venue specified",
              "No DOI available",
              "No meaningful snippet"
            ],
            "completeness": 28.57142857142857
          }
        ]
      }
    },
    "fallback_robustness": {
      "score": 0.0
    },
    "asks_questions": {
      "score": 0.0
    },
    "rag_fidelity": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 2.0,\n  \"rationale\": \"The agent provides a comprehensive and detailed 6-month plan for AI-driven cancer drug discovery, specifically targeting non-small cell lung cancer (NSCLC) with EGFR mutations. It accurately synthesizes information from the provided citations, using them to support specific objectives and experimental designs. For example, [P1] is cited for multi-omics integration and [P3] for structure-based drug discovery, aligning with the plan's experiments. The plan is well-structured, with clear objectives, measurable outcomes, and a detailed experimental breakdown, demonstrating a strong grounding in the cited evidence and best practices in AI research.\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent provides a comprehensive and detailed 6-month plan for AI-driven cancer drug discovery, specifically targeting non-small cell lung cancer (NSCLC) with EGFR mutations. It accurately synthesizes information from the provided citations, using them to support specific objectives and experimental designs. For example, [P1] is cited for multi-omics integration and [P3] for structure-based drug discovery, aligning with the plan's experiments. The plan is well-structured, with clear objectives, measurable outcomes, and a detailed experimental breakdown, demonstrating a strong grounding in the cited evidence and best practices in AI research.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "citation_relevance": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The citations directly support the claims made in the response. For example, [P1] is cited in the 'Problem Framing and Goals' section for 'Multi-omics Integration' and also in the 'Experiments' section for 'Multi-omics Patient Response Prediction', which aligns with the paper's focus on multi-omics data for personalized treatment suggestions. Similarly, [P3] is cited for 'Structure-based drug discovery with deep learning', which is directly relevant to the experiments on drug discovery and molecular generation.\", \"confidence\": \"high\"}",
          "rationale": "The citations directly support the claims made in the response. For example, [P1] is cited in the 'Problem Framing and Goals' section for 'Multi-omics Integration' and also in the 'Experiments' section for 'Multi-omics Patient Response Prediction', which aligns with the paper's focus on multi-omics data for personalized treatment suggestions. Similarly, [P3] is cited for 'Structure-based drug discovery with deep learning', which is directly relevant to the experiments on drug discovery and molecular generation.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "source_fit": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent provides a comprehensive and detailed 6-month plan for using AI in cancer drug discovery, specifically targeting NSCLC. The plan is well-structured, outlining clear objectives, experiments with hypotheses and ablations, a realistic timeline, and relevant citations. The sources used (academic papers from arXiv and reputable scientific journals/institutions) are highly appropriate for the user's ambitious goal, demonstrating a deep understanding of the domain and the current state of AI in drug discovery. The recency of the cited papers (mostly 2022-2024) is also a strong indicator of relevance.\", \"confidence\": \"high\"}",
          "rationale": "The agent provides a comprehensive and detailed 6-month plan for using AI in cancer drug discovery, specifically targeting NSCLC. The plan is well-structured, outlining clear objectives, experiments with hypotheses and ablations, a realistic timeline, and relevant citations. The sources used (academic papers from arXiv and reputable scientific journals/institutions) are highly appropriate for the user's ambitious goal, demonstrating a deep understanding of the domain and the current state of AI in drug discovery. The recency of the cited papers (mostly 2022-2024) is also a strong indicator of relevance.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "citation_quality": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent provides a detailed, well-structured plan that addresses the user's (unrealistic) request by reframing it into a feasible AI-driven drug discovery project. The plan includes specific objectives, experiments with hypotheses and ablations, a timeline, and relevant citations. The citations are scholarly (arXiv preprints) and directly support the claims made within the plan, particularly regarding AI in precision oncology, drug discovery, and multi-omics data. The formatting is clear and the content is highly relevant to the prompt.\", \"confidence\": \"high\"}",
          "rationale": "The agent provides a detailed, well-structured plan that addresses the user's (unrealistic) request by reframing it into a feasible AI-driven drug discovery project. The plan includes specific objectives, experiments with hypotheses and ablations, a timeline, and relevant citations. The citations are scholarly (arXiv preprints) and directly support the claims made within the plan, particularly regarding AI in precision oncology, drug discovery, and multi-omics data. The formatting is clear and the content is highly relevant to the prompt.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "question_quality": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The agent provides a highly detailed and structured plan that directly addresses the user's ambitious goal by breaking it down into manageable, albeit still very complex, research objectives. It grounds the plan in reality by acknowledging the impossibility of the user's timeline while offering a feasible, albeit still aggressive, 6-month research execution plan. The plan includes specific, measurable objectives, a detailed breakdown of experiments with hypotheses, setups, ablations, and expected outcomes, and a timeline. This demonstrates a strong understanding of the user's intent and provides a targeted, contextually relevant, and actionable response.\", \"confidence\": \"high\"}",
          "rationale": "The agent provides a highly detailed and structured plan that directly addresses the user's ambitious goal by breaking it down into manageable, albeit still very complex, research objectives. It grounds the plan in reality by acknowledging the impossibility of the user's timeline while offering a feasible, albeit still aggressive, 6-month research execution plan. The plan includes specific, measurable objectives, a detailed breakdown of experiments with hypotheses, setups, ablations, and expected outcomes, and a timeline. This demonstrates a strong understanding of the user's intent and provides a targeted, contextually relevant, and actionable response.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "actionability": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 1.0, \"rationale\": \"The response provides a highly detailed and actionable 6-month plan for AI-driven cancer drug discovery. It breaks down the objective into specific, measurable goals, outlines 7 core experiments with detailed hypotheses, setups, ablations, metrics, and expected outcomes. The timeline is also clearly defined with bi-weekly sprints and deliverables. Crucially, it includes concrete steps like specifying models (e.g., GraphDTA, VAEs, GNNs), datasets (e.g., PDBbind, ChEMBL, TCGA), hardware (e.g., A100 GPUs), and evaluation metrics (e.g., AUC, Pearson R, hit rate). The plan also suggests specific commands and parameters implicitly through the description of models, datasets, and experimental setups, which a user could translate into actual code and execution. The expected outcomes provide clear targets for success.\", \"confidence\": \"high\"}",
          "rationale": "The response provides a highly detailed and actionable 6-month plan for AI-driven cancer drug discovery. It breaks down the objective into specific, measurable goals, outlines 7 core experiments with detailed hypotheses, setups, ablations, metrics, and expected outcomes. The timeline is also clearly defined with bi-weekly sprints and deliverables. Crucially, it includes concrete steps like specifying models (e.g., GraphDTA, VAEs, GNNs), datasets (e.g., PDBbind, ChEMBL, TCGA), hardware (e.g., A100 GPUs), and evaluation metrics (e.g., AUC, Pearson R, hit rate). The plan also suggests specific commands and parameters implicitly through the description of models, datasets, and experimental setups, which a user could translate into actual code and execution. The expected outcomes provide clear targets for success.",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "persona_compliance": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The AI adopts a guiding and encouraging tone throughout the response. It begins by acknowledging the user's ambitious goal while gently grounding it in scientific reality, stating that 'curing cancer tomorrow' is impossible but AI can accelerate research. The AI then proceeds to provide a detailed, structured plan, framing it as a focused effort on AI-enhanced drug discovery for a specific cancer type. The language used is supportive and forward-looking, offering a concrete path forward rather than dismissing the user's initial, albeit unrealistic, request.\", \"confidence\": \"high\"}",
          "rationale": "The AI adopts a guiding and encouraging tone throughout the response. It begins by acknowledging the user's ambitious goal while gently grounding it in scientific reality, stating that 'curing cancer tomorrow' is impossible but AI can accelerate research. The AI then proceeds to provide a detailed, structured plan, framing it as a focused effort on AI-enhanced drug discovery for a specific cancer type. The language used is supportive and forward-looking, offering a concrete path forward rather than dismissing the user's initial, albeit unrealistic, request.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "stage_awareness": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The user's prompt expresses an ambitious and unrealistic goal ('cure cancer tomorrow'). The agent correctly identifies this as a research stage where the user needs a reality check and a more focused, achievable plan. The response then provides a detailed, structured, and realistic 6-month plan for AI-driven drug discovery targeting a specific cancer type (NSCLC), demonstrating a clear understanding of the user's (implied) research stage and tailoring the guidance accordingly. The plan includes problem framing, specific experiments with hypotheses and ablations, a timeline, and relevant citations, all of which are appropriate for someone looking to embark on a complex research project.\", \"confidence\": \"high\"}",
          "rationale": "The user's prompt expresses an ambitious and unrealistic goal ('cure cancer tomorrow'). The agent correctly identifies this as a research stage where the user needs a reality check and a more focused, achievable plan. The response then provides a detailed, structured, and realistic 6-month plan for AI-driven drug discovery targeting a specific cancer type (NSCLC), demonstrating a clear understanding of the user's (implied) research stage and tailoring the guidance accordingly. The plan includes problem framing, specific experiments with hypotheses and ablations, a timeline, and relevant citations, all of which are appropriate for someone looking to embark on a complex research project.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "tone_constructive": {
      "score": 2.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 2.0, \"rationale\": \"The response begins by acknowledging the user's ambitious goal and immediately provides a realistic perspective, stating that curing cancer tomorrow is scientifically impossible. It then pivots to a constructive approach by focusing on what *is* achievable with AI in cancer research, specifically AI-enhanced drug discovery for a particular cancer type. The plan is detailed, well-structured, and outlines measurable objectives and a clear timeline. The tone is encouraging and empowering, framing the challenge as a complex but addressable scientific endeavor. The use of terms like \\\"accelerate,\\\" \\\"develop,\\\" and \\\"validate\\\" suggests a proactive and solution-oriented mindset. The detailed breakdown of experiments, timelines, and deliverables further reinforces a sense of progress and achievable goals, which is motivating.\", \"confidence\": \"high\"}",
          "rationale": "The response begins by acknowledging the user's ambitious goal and immediately provides a realistic perspective, stating that curing cancer tomorrow is scientifically impossible. It then pivots to a constructive approach by focusing on what *is* achievable with AI in cancer research, specifically AI-enhanced drug discovery for a particular cancer type. The plan is detailed, well-structured, and outlines measurable objectives and a clear timeline. The tone is encouraging and empowering, framing the challenge as a complex but addressable scientific endeavor. The use of terms like \"accelerate,\" \"develop,\" and \"validate\" suggests a proactive and solution-oriented mindset. The detailed breakdown of experiments, timelines, and deliverables further reinforces a sense of progress and achievable goals, which is motivating.",
          "confidence": "high",
          "score": 2.0
        }
      ]
    },
    "expectation_management": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 1, \"rationale\": \"The agent correctly identifies that curing cancer \\\"tomorrow\\\" is an infeasible goal and explicitly states this. It then reframes the goal to a more realistic and achievable objective: \\\"AI-enhanced drug discovery for a specific cancer type\\\" with measurable milestones. This demonstrates effective expectation management.\", \"confidence\": \"high\"}",
          "rationale": "The agent correctly identifies that curing cancer \"tomorrow\" is an infeasible goal and explicitly states this. It then reframes the goal to a more realistic and achievable objective: \"AI-enhanced drug discovery for a specific cancer type\" with measurable milestones. This demonstrates effective expectation management.",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "plan_completeness": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\n  \"score\": 1,\n  \"rationale\": \"The response includes hypotheses, methodology (detailed experiments with ablations), evaluation metrics, resources (hardware mentioned), and milestones (timeline with deliverables).\",\n  \"confidence\": \"high\"\n}",
          "rationale": "The response includes hypotheses, methodology (detailed experiments with ablations), evaluation metrics, resources (hardware mentioned), and milestones (timeline with deliverables).",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "risk_mitigation": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "```json\n{\n  \"score\": 1,\n  \"rationale\": \"The agent has provided a detailed 6-month plan for AI-driven cancer drug discovery. Each experiment is paired with specific hypotheses, setup details, ablations, baselines, metrics, and expected outcomes. This demonstrates a clear pairing of research activities (risks, in a broad sense of challenges to overcome) with mitigation strategies (the experimental design and evaluation plan).\",\n  \"confidence\": \"high\"\n}\n```",
          "rationale": "The agent has provided a detailed 6-month plan for AI-driven cancer drug discovery. Each experiment is paired with specific hypotheses, setup details, ablations, baselines, metrics, and expected outcomes. This demonstrates a clear pairing of research activities (risks, in a broad sense of challenges to overcome) with mitigation strategies (the experimental design and evaluation plan).",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "feasibility_analysis": {
      "score": 1.0,
      "judges": [
        {
          "judge": "openrouter:google/gemini-2.5-flash-lite",
          "raw": "{\"score\": 1, \"rationale\": \"The response provides a detailed 6-month plan for AI-driven cancer drug discovery, explicitly addressing skills (e.g., GNNs, VAEs, RL, federated learning), data (e.g., PDBbind, ChEMBL, TCGA, multi-omics), and compute (e.g., A100 GPUs, cluster setup). It breaks down experiments, timelines, and success criteria, demonstrating a comprehensive feasibility analysis.\", \"confidence\": \"high\"}",
          "rationale": "The response provides a detailed 6-month plan for AI-driven cancer drug discovery, explicitly addressing skills (e.g., GNNs, VAEs, RL, federated learning), data (e.g., PDBbind, ChEMBL, TCGA, multi-omics), and compute (e.g., A100 GPUs, cluster setup). It breaks down experiments, timelines, and success criteria, demonstrating a comprehensive feasibility analysis.",
          "confidence": "high",
          "score": 1.0
        }
      ]
    },
    "evidence_integrity": {
      "score": 1.0,
      "details": {
        "validity": 1.0,
        "rag_fidelity": 2.0
      }
    }
  },
  "judge_models": [
    "openrouter:google/gemini-2.5-flash-lite"
  ],
  "output_label": "judge_seed1_absolute_mentor_manual",
  "metrics_version": 2,
  "metrics_config_digest": "02ce838023f18d5d55c763e958282c8b763170b4fd1eac60c7b7445ce4e48453",
  "judge_prompt_digest": "45b272cee244d8cdeb02c717f98a4081be50d9cd712b6616c7240ae927ec513d",
  "citation_domains_digest": "81cdd2fb63c3b437b7a1fba0f2304715e28ac3b4c5f400507ad7a352bb78c367",
  "metric_prompt_digests": {
    "rag_fidelity": "660c53926744ab90570c53c1f01f95a01418055d91d2d572548404a03d341213",
    "citation_relevance": "98e8253bb21908885984e8b0e785770109f8ba9d552643caf8ba1e3374ad890a",
    "source_fit": "52b3a41c4befe563c4dad55f6bd214485f3cc0131b5cf012675c50494bf7dcfc",
    "citation_quality": "5259dca527f992d0505c3ee9b5c3462b2a12897e148dbccd09312c272e4bf63d",
    "question_quality": "21ac2c52f156b8e695896d2ed07a15dd63eb2467ad3bb5f57c1e0dae7b99d80a",
    "actionability": "5d9aca0197762fc715b04d74d93cdc2b1e856fc08c308d2dcf7c28ab5a23f25e",
    "persona_compliance": "c27b9859c4cc18a4f43399259b5ffdb58e8c26904250229e6f92898eaf88ab18",
    "stage_awareness": "5b1b7f17ec0646db3d593e6dd649d1071bd6192f0ce5f23634ba8c3d467eef81",
    "tone_constructive": "e838330719f56aee975d84dc2fed7aeb1ed12fbe6af2763f3a1f52c76bf6f246",
    "expectation_management": "537d0916b79eefb7a55b23ef48d10cc981035067109054d7e29e04fe4e91470f",
    "plan_completeness": "f7d0e4d18670ffd18d4fb2b6c2b1f1db75a52b6f49956113b079dd6ff44e315f",
    "risk_mitigation": "0d372e749228777994b8302c4f4da77820fd56fa3bb11982a274fa3a3ec9f5a8",
    "feasibility_analysis": "1641c449a082419af5efdc972d708b763f96f0567dc9144a7ae89365076782b4"
  },
  "model_params": null,
  "model_spec": {
    "provider": null,
    "model": null,
    "system_id": "mentor_manual",
    "system_alias": null
  },
  "expected_checks": [
    "tool_routing",
    "rag_fidelity",
    "fallback_robustness",
    "citation_presence",
    "citation_validity",
    "citation_relevance",
    "source_fit",
    "citation_quality",
    "question_quality",
    "asks_questions",
    "actionability",
    "persona_compliance",
    "stage_awareness",
    "tone_constructive",
    "expectation_management",
    "plan_completeness",
    "risk_mitigation",
    "feasibility_analysis"
  ],
  "judge_parameters": [
    {
      "spec": "openrouter:google/gemini-2.5-flash-lite",
      "temperature": 0.0,
      "max_tokens": 1024
    }
  ]
}